(CercleFinance.com) – The title Reckitt fell sharply Monday on the London Stock Exchange, penalized by a downgrading of the board of Deutsche Bank passed to ‘hold’ against ‘buy’ previously.
Around 11:15 a.m. (local time), the action of the British daily consumer group fell 0.8% while, at the same time, the FTSE 100 index lost less than 0.4%.
In a note, Deutsche Bank analysts say they are worried about “headwinds” preventing, according to them, a stock market revaluation of the owner of the Strepsils or Nurofen brands.
The design office explains that it perceives only a limited number of catalysts likely to bring value in the short term.
“Reckitt has delivered what may appear to be cautious forecasts, recalls Deutsche Bank, but on paper no growth in earnings per share (EPS) is on the program for the 2023 financial year”, he underlines.
Recalling that Reckitt’s business remains highly dependent on seasonal viruses, analysts say they are concerned about a flu season deemed less intense than usual and losses of market share in infant formula in the United States. United.
Copyright (c) 2023 CercleFinance.com. All rights reserved.